Abstract
9588 Background: ONJ is diagnosed with increasing frequency among IV bisphosponate (IVBP)-treated cancer pts, in the range of 1–10 per 100 treated pts depending on duration of therapy (Khosla 2007)...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have